ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q4Scopus Q3SCImago #9,071Hybrid

American Journal of Clinical Oncology-Cancer Clinical Trials

Abbreviation (ISO):AM J CLIN ONCOL-CANC
•
Identifier (ISSN):0277-3732(Print)/1537-453X(Online)
•
Publisher:Lippincott Williams and Wilkins Ltd.
Clarivate IF (2026)
1.8– 0
Journal Impact Factor
IF Trend↓
WoS Quartile
Q4
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for American Journal of Clinical Oncology-Cancer Clinical Trials

WoS Q4
12453.4220183.0220191.9120202.3420212.7920222.620231.620241.820251.82026
Annual Impact Factor Metric
Current (2026):1.8
Scopus SJR & RankScopus Q3
0.647
#9,071

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
95

95 papers with at least that number of citations each

WoS: SCIE / JCRQ4
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
94articles/year
10.93% Gold OA•85.53% Original Research

Aims & Scope

​​​​​​​American Journal of Clinical Oncology is a multidisciplinary journal for cancer surgeons, radiation oncologists, medical oncologists, GYN oncologists, and pediatric oncologists. The emphasis of AJCO is on combined modality multidisciplinary loco-regional management of cancer. The journal also gives emphasis to translational research, outcome studies, and cost utility analyses, and includes opinion pieces and review articles. The editorial board includes a large number of distinguished surgeons, radiation oncologists, medical oncologists, GYN oncologists, pediatric oncologists, and others who are internationally recognized for expertise in their fields.

Topics Covered (Recognized by AI)
Medicine98.9%Internal medicine90.9%Biology89%Genetics81.9%Surgery77.9%Pathology64.4%Cancer61.1%Oncology48.9%Chemotherapy46.7%Radiology45.1%Chemistry36.7%Radiation therapy35.8%Gastroenterology27%Organic chemistry23.5%Immunology22.3%Toxicity21.1%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ONCOLOGY

Q4
Rank264/333
IndexSCIE
JCISCIE2026

ONCOLOGY

Q4
Rank266/333
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF1.8
Articles / Year81
Total Citations7
2025
IF1.8
Articles / Year126
Total Citations171
2024
IF1.6
Articles / Year80
Total Citations254
2023
IF2.6
Articles / Year106
Total Citations607
2022
IF2.787
Articles / Year89
Total Citations500

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #9,071Scopus Q3SCImago Profile
Scopus Coverage:1982-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q3
0.647

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3
Citations / Doc (2 years)
1.73

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,160 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations452
3-Year Documents257
Citable Documents242

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate43.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cancer ResearchQ3
OncologyQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

American Journal of Clinical Oncology-Cancer Clinical Trials (abbr: AM J CLIN ONCOL-CANC, ISSN: 0277-3732) is a peer-reviewed international scholarly journal in the field of Medicine, published by Lippincott Williams and Wilkins Ltd. in United States since 1982. The periodical holds a Journal Impact Factor (JIF) of 1.80, ranking in quartile Q4 of Web of Science (SCIE), a Scopus SJR indicator of 0.647 (Q3), an H-index of 95.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 94 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,160 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Lippincott Williams and Wilkins Ltd.
Publication Language
English
Frequency
Bimonthly
Founding Year
1982
Indexing & Databases
SCIEScopusPubMed
Editorial Address
LIPPINCOTT WILLIAMS & WILKINS, 530 WALNUT ST, PHILADELPHIA, USA, PA, 19106-3621

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 59cd3f8f-01eb-48f1-ab23-fdf290274a10
Database Updated: 2026-09-28